Investment
Features
FeesSafety
Academy
More
Pluang+

San Juan Basin Royalty Trust updates on expenses, audit, and credit facility ahead of 2027 maturity

Market News
28 Sep 2026
PRNewsWire
View Source
Neutral
San Juan Basin Royalty Trust updates on expenses, audit, and credit facility ahead of 2027 maturity

San Juan Basin Royalty Trust, managed by Argent Trust Company, provided updates on administrative expenses, audit adjustments, and liquidity. The Trust reported a $976,000 decrease in expenses due to the 2024 trustee transition and changes in audit consultants. The 2017–2020 joint interest audit was inherited from the previous trustee and concluded with no further dispute pursued. The Trust also disclosed ongoing monitoring of Hilcorp's capital expenditures and plans to extend or replace its $2 million credit facility maturing in May 2027. Additionally, the Trust will resume national newswire distribution of monthly press releases to improve investor communication.

San Juan Basin Royalty Trust updates on operations and liquidity. For readers following the Energy sector, here is Pluang's market snapshot as of Sep 29, 2026 00:22 WIB: of 38 priced Energy-sector US stocks tradable on Pluang, 16 rose and 22 fell today. LNG (Cheniere Energy) was priced at USD 271.62 with a 1-day change of +1.15% and a typical hold time of 7 days. CVX (Chevron Corp) stood at USD 206.57, up 1.04%, with a typical hold time of 101 days. CCJ (Cameco) was at USD 87.20, down 0.99%, with a typical hold time of 4 days.

More News

XDC token rises amid increased derivatives activity and potential selling near resistance zone

XDC token rises amid increased derivatives activity and potential selling near resistance zone

The XDC token of the XDC Network saw gains over a 24-hour period, ranking among the top three gainers by market cap with about $719 million. Increased derivatives activity, including an 18% rise in open interest to $7.12 million and a positive fundin...

Technical Signals
Bullish
4 hours ago
Vertex Pharmaceuticals rises on strong cystic fibrosis sales and promising kidney drug trials, UBS hikes price target.

Vertex Pharmaceuticals rises on strong cystic fibrosis sales and promising kidney drug trials, UBS hikes price target.

Vertex Pharmaceuticals reported a 12% revenue increase to $3.33 billion in Q2, driven by its dominant cystic fibrosis treatments. UBS raised its price target from $585 to $615, reflecting confidence in Vertex's strong financials and growth potential....

Analyst Insights
Bullish
4 hours ago
XDC Network shows bullish gains but faces resistance at key supply zone amid mixed market signals.

XDC Network shows bullish gains but faces resistance at key supply zone amid mixed market signals.

XDC Network experienced notable gains recently, ranking third among the top 100 tokens by market cap with a $719 million valuation. The price has entered a critical supply zone that has historically capped its upward movement, causing some price reje...

Technical Signals
Bullish
4 hours ago
Uber stock falls 13% in a month amid sector-wide pressure, raising buy-or-sell questions.

Uber stock falls 13% in a month amid sector-wide pressure, raising buy-or-sell questions.

Uber's stock dropped 13% over the past month, underperforming large-cap tech but faring better than rivals Lyft and DoorDash, which fell 15% and 24% respectively. This decline reflects broader weakness in the rideshare and delivery sector, as well as...

Market News
Bearish
4 hours ago
Rush Gold completes acquisition of Landy Investments, gaining mining rights in Nevada projects.

Rush Gold completes acquisition of Landy Investments, gaining mining rights in Nevada projects.

Rush Gold Corp. has finalized its acquisition of Landy Investments Ltd., securing rights to two mining projects in Nevada: a 100% stake in the Douglas Canyon gold/antimony project and an 80% stake in the Hollow North-South copper/gold project. The de...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App